The presence of prostate-specific antigen checked more than 1 year before diagnostic biopsy is an independent prognostic factor in patients undergoing radical prostatectomy

PURPOSE: In large scale prospective studies, prostate-specific antigen (PSA)-screening not only decreased prostate cancer mortality, but also reduced biochemical recurrence (BCR) in patients undergoing radical prostatectomy (RP). We investigated the independent effect of the presence of PSA checked...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Sung Gon, Shim, Kang Hee, Choo, Seol Ho, Kim, Se Joong, Kim, Sun Il
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246017/
https://www.ncbi.nlm.nih.gov/pubmed/34085793
http://dx.doi.org/10.4111/icu.20200545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246017/
https://www.ncbi.nlm.nih.gov/pubmed/34085793
http://dx.doi.org/10.4111/icu.20200545

Ejemplares similares